Increasing threats from SARS-CoV-2 variants: Time to establish global surveillance

Sci Transl Med. 2021 Jul 7;13(601):eabj6984. doi: 10.1126/scitranslmed.abj6984.

Authors

Scott P Layne^{1

2}, Jeffery K Taubenberger^{1

2}

Affiliations

¹ Saint Johns Cancer Institute, Santa Monica, CA and is Emeritus Professor at the Department of Epidemiology, UCLA School of Public Health, Los Angeles, CA, USA. Email: scottplayne@gmail.com.
² Chief of the Viral Pathogenesis and Evolution Section, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA. Email: taubenbergerj@niaid.nih.gov.

No abstract available

Publication types

Editorial
Research Support, N.I.H., Intramural

MeSH terms

COVID-19*
Humans
Public Health
RNA, Viral
SARS-CoV-2*

Substances

RNA, Viral

Grants and funding

ZIA AI001271/ImNIH/Intramural NIH HHS/United States